Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
Introduction: In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindicatio...
Saved in:
Main Authors: | Flaminia Bardanzellu (Author), Cristina Piras (Author), Alessandra Atzei (Author), Paola Neroni (Author), Vassilios Fanos (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How could metabolomics change pediatric health?
by: Flaminia Bardanzellu, et al.
Published: (2020) -
Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
by: Andrii V Maksymenko, et al.
Published: (2019) -
Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014) -
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012) -
Large patent ductus arteriosus: To close or not to close
by: Jaganmohan Tharakan, et al.
Published: (2012)